Incannex Healthcare Limited
Incannex Healthcare Limited (IXHL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IXHL · as of Jun 8, 2026
Key Statistics
Explore Incannex Healthcare Limited Data
ixhl stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
ixhl competitorsIXHL
AGEN
CGTX
IRD
LUCD
SCLXStock Performance
Full HistoryAbout Incannex Healthcare Limited
Incannex Healthcare Limited is an Australian company dedicated to the research, development, and commercialization of medicinal cannabinoid products. The firm offers pharmaceutical-grade cannabinoid c…
what is incannex healthcare limited · ixhl stock overview · incannex healthcare limited company profile · who is incannex healthcare limited ceo · ixhl NASDAQ · incannex healthcare limited headquarters · incannex healthcare limited business segments
About Stock Overview & Key Data
Incannex Healthcare Limited (IXHL) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Mar 2, 2022. As of the latest trading session, IXHL stock price is $3.40, with a market capitalization of $39.0M. The stock has returned -40.97% over the past 12 months and -68.34% year-to-date.
In fiscal year 2025, Incannex Healthcare Limited reported revenue of $86000.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Incannex Healthcare Limited (IXHL) stock price is $3.40. The stock is traded on NASDAQ under the ticker symbol IXHL. The 52-week range is $2.49 – $49.80.